The genesis of Crystal Pharma began in 1991 as a R & D company. Since that beginning, always focusing on innovation, the organization has moved forward to large scale commercial API production, in 1997. Beginning with a varied portfolio of general APIs, Crystal has moved into other specialty areas with time, including high potency hormones and sterile steroids (by filtration). Growth has been very robust with recent annual growth approaching 30%. As of 2007, Crystal is a business unit of Gadea Grupo Farmacéutico. The strength of the entire Gadea group gives us further financial stability and growth and has positioned Crystal as a key player.